Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hurni

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biotechnology and Bioengineering|February 1, 1979
High-resolution flow-zonal centrifuge systemW J McAleer, W Hurni, E Wasmuth, et al.
Vaccine|July 1, 1997
The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adultsP D Reuman, P Kubilis, W Hurni, et al.
Journal of Medical Virology|November 1, 1993
Sensitive assays for hepatitis A antibodiesW J Miller, W Clark, W Hurni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccineD S Laufer, W Hurni, B Watson, et al.
Journal of Medical Virology|July 1, 1996
Duration of protection from clinical hepatitis A disease after vaccination with VAQTAB L Wiens, N R Bohidar, J G Pigeon, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen yearsC E Johnson, M L Kumar, J K Whitwell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biotechnology and Bioengineering|February 1, 1979
High-resolution flow-zonal centrifuge systemW J McAleer, W Hurni, E Wasmuth, et al.
Vaccine|July 1, 1997
The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adultsP D Reuman, P Kubilis, W Hurni, et al.
Journal of Medical Virology|November 1, 1993
Sensitive assays for hepatitis A antibodiesW J Miller, W Clark, W Hurni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Saliva and serum as diagnostic media for antibody to hepatitis A virus in adults and in individuals who have received an inactivated hepatitis A vaccineD S Laufer, W Hurni, B Watson, et al.
Journal of Medical Virology|July 1, 1996
Duration of protection from clinical hepatitis A disease after vaccination with VAQTAB L Wiens, N R Bohidar, J G Pigeon, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen yearsC E Johnson, M L Kumar, J K Whitwell, et al.
Pageof 1